Skip to main content
. 2014 Jul 7;6(1):e2014054. doi: 10.4084/MJHID.2014.054

Figure 5.

Figure 5

(A) Comparison of the percentages (mean ± SD) of erythroid precursors expressing caspase 3 (casp. 3+CD71+CD45−) at the bone marrow level in normal donors (white bar), in AS trait carrier donors (dashed bar), in SCA patients at baseline (gray bar), and after 60 days post-transplant (black bar). (B, C) Flow cytometric analysis of erythroid compartment for caspase 3 expression in SCA patients at baseline (B) and after 60 days post-transplant (C).